Tarveda Therapeutics Alternatives & Competitors
12 companies similar to Tarveda Therapeutics — To discover, develop and commercialize a new class of potent and selective preci...
Companies similar to Tarveda Therapeutics
Pacylex Pharmaceuticals, Inc.
A new target in cancer care - triggering selective lethality with a new class of drugs.
Edmonton, Canada
iOnctura
Developing precision small molecules to combat hard-to-treat tumors.
Geneve, Switzerland
Epsilogen Ltd
Harnessing the power of IgE
United Kingdom
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
United States
Rival Readout
Competing with Tarveda Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ImmunoMet Therapeutics, Inc.
Targeting Metabolic Reprogramming in Fibrosis and Oncology
Seattle, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
March Biosciences
Transforming patient care in the most challenging leukemias and lymphomas
Houston, United States
Carisma Therapeutics
Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors
Philadelphia, United Stat...
ProfoundBio
An oncology biotherapeutics company
Woodinville, United State...
Sierra Oncology
We are on a mission to deliver transformative therapies that treat rare forms of cancer.
San Mateo, United States
About Tarveda Therapeutics
Tarveda Therapeutics, founded in 2011, is a clinical-stage biopharmaceutical company focused on developing a new class of potent and selective precision oncology medicines. Its cutting-edge technology, branded as Pentarin® miniature drug conjugates, targets solid tumor malignancies. These conjugates are engineered to p...
Precision Oncology, Biopharmaceuticals, Drug Development, Solid Tumor Treatment, Miniature Drug Conjugates, Pentarin Technology, Targeted Cancer Therapy, HSP90 Binding, Topoisomerase 1 Inhibitor, Phase 2a Clinical Trials, Cancer Payload Delivery, Somatostatin Receptor 2 Therapy, Kinase Inhibitors, Radioisotope Drug Conjugates, Neuroendocrine Tumor Treatment
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Tarveda Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Tarveda Therapeutics on 13 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
